We are live on
!
Find out more
Russell Investments Group Portfolio holdings
AUM
$114B
1-Year Est. Return
41.71%
This Fund
S&P 500
This Quarter
Est. Return
+3.91%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
–
AUM
$91.8B
AUM Growth
+$3.73B
(+4.2%)
Cap. Flow
+$1.79B
Cap. Flow
% of AUM
1.95%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
4,287
New
142
Increased
1,915
Reduced
1,685
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$272M |
| 2 |
Apple
AAPL
|
+$272M |
| 3 |
NVIDIA
NVDA
|
+$265M |
| 4 |
TotalEnergies
TTE
|
+$166M |
| 5 |
Broadcom
AVGO
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$184M |
| 2 |
Welltower
WELL
|
+$125M |
| 3 |
TSMC
TSM
|
+$110M |
| 4 |
Prologis
PLD
|
+$94.6M |
| 5 |
VICI Properties
VICI
|
+$72.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.19% |
| 2 | Financials | 13.73% |
| 3 | Consumer Discretionary | 10.21% |
| 4 | Healthcare | 9.88% |
| 5 | Communication Services | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Critical Metals Corp
CRML
$967M
| $23.5K | ﹤0.01% |
3,386
+416
| +14% | +$4.54K |
|
|
MPLT
3452
MapLight Therapeutics
MPLT
$525M
| $23.5K | ﹤0.01% |
+1,337
| New | +$22.4K |
|
3453
VanEck Retail ETF
RTH
$259M
| $23.5K | ﹤0.01% |
+94
| New | +$23.6K |
|
3454
Perspective Therapeutics
CATX
$354M
| $23.3K | ﹤0.01% |
8,477
+28
| +0.3% | +$80 |
|
3455
Lightbridge
LTBR
$327M
| $23.1K | ﹤0.01% |
1,831
-649
| -26% | -$12.5K |
|
3456
WisdomTree US High Dividend Fund
DHS
$1.6B
| $23.1K | ﹤0.01% |
227
+11
| +5% | +$1.11K |
|
3457
Avantis Emerging Markets Equity ETF
AVEM
$27B
| $23K | ﹤0.01% |
299
-243
| -45% | -$18.6K |
|
3458
Bel Fuse Inc Class A
BELFA
$3.4B
| $22.9K | ﹤0.01% |
151
+6
| +4% | +$805 |
|
|
SMLR
3459
DELISTED
Semler Scientific
SMLR
| $22.9K | ﹤0.01% |
1,497
-256
| -15% | -$5.81K |
|
3460
Fidelity High Dividend ETF
FDVV
$10.5B
| $22.8K | ﹤0.01% |
402
+96
| +31% | +$5.39K |
|
|
SMC
3461
Summit Midstream
SMC
$480M
| $22.8K | ﹤0.01% |
854
| – | – |
|
|
TBRG
3462
DELISTED
TruBridge
TBRG
| $22.7K | ﹤0.01% |
1,029
+83
| +9% | +$1.74K |
|
|
MBCN
3463
DELISTED
Middlefield Banc Corp
MBCN
| $22.7K | ﹤0.01% |
656
+51
| +8% | +$1.69K |
|
3464
First Western Financial
MYFW
$309M
| $22.5K | ﹤0.01% |
841
| – | – |
|
3465
Larimar Therapeutics
LRMR
$444M
| $22.5K | ﹤0.01% |
5,917
+1,069
| +22% | +$4.16K |
|
3466
Fennec Pharmaceuticals
FENC
$423M
| $22.5K | ﹤0.01% |
2,924
-750
| -20% | -$6.16K |
|
3467
US Gold Corp
USAU
$249M
| $22.4K | ﹤0.01% |
1,156
-4,452
| -79% | -$76.1K |
|
3468
Landmark Bancorp
LARK
$197M
| $22.4K | ﹤0.01% |
856
+461
| +117% | +$12.1K |
|
|
FSFG
3469
DELISTED
First Savings Financial Group
FSFG
| $22.4K | ﹤0.01% |
703
-145
| -17% | -$4.51K |
|
3470
Ohio Valley Banc Corp
OVBC
$218M
| $22.3K | ﹤0.01% |
559
+244
| +77% | +$9.19K |
|
3471
Hercules Capital
HTGC
$3.17B
| $22.3K | ﹤0.01% |
1,187
+667
| +128% | +$12K |
|
3472
Monopar Therapeutics
MNPR
$741M
| $22.3K | ﹤0.01% |
341
+4
| +1% | +$327 |
|
3473
Fidelity Value Factor ETF
FVAL
$1.38B
| $22.3K | ﹤0.01% |
308
+271
| +732% | +$19.1K |
|
3474
PrimeEnergy Resources
PNRG
$316M
| $22.2K | ﹤0.01% |
130
+30
| +30% | +$4.82K |
|
3475
Inhibikase Therapeutics
IKT
$378M
| $22.2K | ﹤0.01% |
10,814
+3,112
| +40% | +$4.95K |
|
Similar funds
Russell Investments Group's Q4 2025 Portfolio in Review
As of Q4 2025, Russell Investments Group held 4,287 positions worth $91.8B, up 4.2% from $88.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Russell Investments Group's Q4 2025 filing shows 142 new, 1,915 increased, 1,685 reduced and 109 closed positions. Its largest new stake was The Southern Company 2025 Series A Corp Units: 2,772,500 shares worth $2.79M. The largest sale was Bank of America Series L, an estimated $184M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Russell Investments Group's largest Q4 2025 buy was The Southern Company 2025 Series A Corp Units: 2,772,500 shares worth $2.79M.
- Russell Investments Group added most to iShares Core US Aggregate Bond ETF in Q4 2025, an estimated $272M increase.
- Russell Investments Group's biggest Q4 2025 reduction was Bank of America Series L, cutting an estimated $184M.
- Russell Investments Group fully exited Kellanova in Q4 2025, selling an estimated $20.8M.
- Russell Investments Group's ten largest holdings make up 27% of its $91.8B portfolio in Q4 2025.
- Russell Investments Group opened 142 new positions and closed 109 in Q4 2025.
- Russell Investments Group's portfolio value rose 4.2% quarter-over-quarter to $91.8B.
Based on Russell Investments Group's 13F filing for Q4 2025, filed 17 Feb 2026.